Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
about
Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatmentMaternal autoimmune diseases and immunologically induced embryonic and fetoplacental damageBiochemical characterization of annexin B1 from Cysticercus cellulosae.Imaging aspects of cardiovascular disease at the cell and molecular level.Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.Peripheral protein organization and its influence on lipid diffusion in biomimetic membranes.Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.Atomic force microscopy: High resolution dynamic imaging of cellular and molecular structure in health and disease.Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsHereditary thrombophilic risk factors for recurrent pregnancy loss.Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndromeAnnexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.Antiphospholipid Syndrome during pregnancy: the state of the artAntiphospholipid syndrome: multiple mechanisms.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activityAutoantibodies associated with reproductive failure.Antiphosphatidylserine antibodies and reproductive failure.Insights into the pathophysiology of the antiphospholipid syndrome provided by atomic force microscopy.Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndromeSome antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.Expression and functions of annexins in the kidney.Antibodies against annexin A5: detection pitfalls and clinical associations.Antiphospholipid antibodies: laboratory and pathogenetic aspects.Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.Antiphospholipid syndrome: laboratory testing and diagnostic strategies.Morphological and cytochemical determination of cell death by apoptosis.Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glycoprotein-I antibodies.Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.Antiphospholipid antibodies and lipoprotein(a) in obese children.Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy.
P2860
Q26999710-A4847192-BCF2-4D65-A1E0-2F57E9C09087Q28169065-BF79B9F3-7A5B-4EFB-985F-8150908D2526Q33251190-9CA992A7-9FBF-416F-ABE9-D74CE8F9CEE9Q33338017-3BB01FEE-21CC-43B9-8BE6-F455657085ADQ33747286-12DC9904-6572-42A8-BB9B-960AA443D3FBQ33794115-21BC3E75-3F15-4EAC-80D2-195385AFC57FQ34003992-D0FCF920-5BBD-4606-BE79-BE96218AAB82Q34069117-8F3AE225-F761-4B1A-A27D-273E2E2CC763Q34476952-A8F7266E-6F3A-484F-B759-59950BF37C7DQ34633803-93323E14-2616-414E-AC82-A7653CAA022EQ34749444-A83F4859-61A0-45FC-8CF2-229C40425875Q35067429-EC5931C6-765C-4124-B90B-1450D0B2EEABQ35263482-4BA87798-037F-4C1F-9BB0-EE17656B3143Q35490209-CAD6FC1C-39F1-4DE3-B9D9-23E556D43435Q35638142-BD2BC41A-5F48-43A6-BDCF-B10AA460E4BCQ35756040-D1586335-2F0E-4150-9D18-CB196C742A32Q35775322-60BFF374-E07A-4BD5-BFD4-21FE61BAB6F9Q35849691-EF06A100-5BDC-43F2-9741-50E32103590DQ35852436-CF6FFCEB-24A8-4DCA-A5FD-F529AEBE7D88Q35918355-71F7F229-1199-498F-AE6E-B9653ED633E1Q35918365-EE0D7096-1856-41FE-8D9E-A2EF06EDC6EAQ35927360-F9F150AC-E46F-4015-931D-AFF9DB210DF0Q35945520-EE59ADE1-5A12-4144-966B-2571C939F151Q35945526-86D1B769-67DE-47E7-AC34-1C04083CEF6DQ35946069-C5D4582C-0B6C-4A11-A7A8-B2D3DBCD27CFQ36279511-E6DEDEBF-74E8-48CB-A9E3-4ED321F48523Q36309547-0B33CD0C-FB6D-4C21-AF07-F8934AB5A5ECQ36799474-C1F307A1-965A-4FDA-9036-36BDD6770186Q36843689-B60F96BC-A324-41E2-B6D7-A4EAE7C5A5BBQ36844544-DE7E7C86-3E22-4781-8218-3EE919ADD1F9Q37000428-613D2FA4-97C1-49B6-95B2-7221B3F45AE8Q37283029-96644132-A255-423A-9606-492EFD3F94B3Q37349421-3352227C-F72C-4EB6-8C99-5C40AA04AA09Q37534476-62121036-4781-43E1-991B-AFE18E69D93DQ37721612-733E5B1B-AE8E-433E-BF34-393505DCB94FQ38175886-B4999FF8-2E7C-40F9-8DDD-D97667D5C24AQ38657043-D30047A9-9328-4A25-BEE5-A2E6EDE9A29AQ39079488-62E52DA5-8590-4871-A9B2-BD75CA9D4815Q40006238-283B0AA3-D2D0-4696-881B-D75F1F2F30C3Q42378451-2627A5BB-F221-4DA4-BF3F-ECD7986B31B9
P2860
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Human monoclonal antiphospholi ...... croscopy and functional assay.
@ast
Human monoclonal antiphospholi ...... croscopy and functional assay.
@en
type
label
Human monoclonal antiphospholi ...... croscopy and functional assay.
@ast
Human monoclonal antiphospholi ...... croscopy and functional assay.
@en
prefLabel
Human monoclonal antiphospholi ...... croscopy and functional assay.
@ast
Human monoclonal antiphospholi ...... croscopy and functional assay.
@en
P2093
P2860
P921
P1476
Human monoclonal antiphospholi ...... croscopy and functional assay.
@en
P2093
Anthony S Quinn
Douglas J Taatjes
Edwin G Bovill
Jacob H Rand
Keith R McCrae
Pojen P Chen
Xiao-Xuan Wu
P2860
P304
P356
10.1016/S0002-9440(10)63479-7
P407
P577
2003-09-01T00:00:00Z